BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17726098)

  • 1. Inhibitors of metabolism rescue cell death in Huntington's disease models.
    Varma H; Cheng R; Voisine C; Hart AC; Stockwell BR
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14525-30. PubMed ID: 17726098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria?
    Sawa A
    J Mol Med (Berl); 2001 Jul; 79(7):375-81. PubMed ID: 11466559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
    Naia L; Ferreira IL; Cunha-Oliveira T; Duarte AI; Ribeiro M; Rosenstock TR; Laço MN; Ribeiro MJ; Oliveira CR; Saudou F; Humbert S; Rego AC
    Mol Neurobiol; 2015 Feb; 51(1):331-48. PubMed ID: 24841383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 9 Suppresses Striatal Cell Death Dominantly Through ERK Signaling in Huntington's Disease.
    Yusuf IO; Cheng PH; Chen HM; Chang YF; Chang CY; Yang HI; Lin CW; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
    Cell Physiol Biochem; 2018; 48(2):605-617. PubMed ID: 30021209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
    Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
    Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
    Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
    Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.
    Liévens JC; Iché M; Laval M; Faivre-Sarrailh C; Birman S
    Hum Mol Genet; 2008 Mar; 17(6):882-94. PubMed ID: 18065778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease.
    Besson MT; Dupont P; Fridell YW; Liévens JC
    Hum Mol Genet; 2010 Sep; 19(17):3372-82. PubMed ID: 20566711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology.
    Bodai L; Marsh JL
    Bioessays; 2012 Feb; 34(2):142-8. PubMed ID: 22334892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model.
    Besson MT; Alegría K; Garrido-Gerter P; Barros LF; Liévens JC
    PLoS One; 2015; 10(3):e0118765. PubMed ID: 25761110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease.
    Chiang MC; Chern Y; Huang RN
    Neurobiol Dis; 2012 Jan; 45(1):322-8. PubMed ID: 21907283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.
    Bryan MR; Bowman AB
    Adv Neurobiol; 2017; 18():113-142. PubMed ID: 28889265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila.
    Liévens JC; Rival T; Iché M; Chneiweiss H; Birman S
    Hum Mol Genet; 2005 Mar; 14(5):713-24. PubMed ID: 15677486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
    Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
    Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioenergetic deficits in Huntington's disease iPSC-derived neural cells and rescue with glycolytic metabolites.
    HD iPSC Consortium
    Hum Mol Genet; 2020 Jul; 29(11):1757-1771. PubMed ID: 30768179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington's disease models.
    Smalley JL; Breda C; Mason RP; Kooner G; Luthi-Carter R; Gant TW; Giorgini F
    J Mol Med (Berl); 2016 Feb; 94(2):235-45. PubMed ID: 26428929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.